These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34758617)

  • 21. Characterization of Cholinesterases From Multiple Large Animal Species for Medical Countermeasure Development Against Chemical Warfare Nerve Agents.
    McGarry KG; Schill KE; Winters TP; Lemmon EE; Sabourin CL; Harvilchuck JA; Moyer RA
    Toxicol Sci; 2020 Mar; 174(1):124-132. PubMed ID: 31879781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
    Darreh-Shori T; Vijayaraghavan S; Aeinehband S; Piehl F; Lindblom RP; Nilsson B; Ekdahl KN; Långström B; Almkvist O; Nordberg A
    Neurobiol Aging; 2013 Nov; 34(11):2465-81. PubMed ID: 23759148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
    Duysen EG; Li B; Lockridge O
    Expert Opin Drug Metab Toxicol; 2009 May; 5(5):523-8. PubMed ID: 19416087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of amiloride with acetylcholinesterase and butyrylcholinesterase.
    Zemach L; Segal D; Shalitin Y
    FEBS Lett; 1990 Apr; 263(1):166-8. PubMed ID: 2332047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations and impaired expression in the ACHE and BCHE genes: neurological implications.
    Soreq H; Ehrlich G; Schwarz M; Loewenstein Y; Glick D; Zakut H
    Biomed Pharmacother; 1994; 48(5-6):253-9. PubMed ID: 7999987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Butyrylcholinesterase distribution in the mouse gastrointestinal tract: An immunohistochemical study.
    Severi I; Abbatelli S; Perugini J; Di Mercurio E; Senzacqua M; Giordano A
    J Anat; 2023 Feb; 242(2):245-256. PubMed ID: 36004682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity.
    Pohanka M
    Int J Mol Sci; 2014 Jun; 15(6):9809-25. PubMed ID: 24893223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The multiple biological roles of the cholinesterases.
    Silman I
    Prog Biophys Mol Biol; 2021 Jul; 162():41-56. PubMed ID: 33307019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase.
    Pohanka M; Dobes P
    Int J Mol Sci; 2013 May; 14(5):9873-82. PubMed ID: 23698772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease.
    Geula C; Darvesh S
    Drugs Today (Barc); 2004 Aug; 40(8):711-21. PubMed ID: 15510242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
    Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
    Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of cholinesterase genes in human oocytes revealed by in-situ hybridization.
    Soreq H; Malinger G; Zakut H
    Hum Reprod; 1987 Nov; 2(8):689-93. PubMed ID: 2830295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.
    Reale M; Costantini E; Di Nicola M; D'Angelo C; Franchi S; D'Aurora M; Di Bari M; Orlando V; Galizia S; Ruggieri S; Stuppia L; Gasperini C; Tata AM; Gatta V
    Sci Rep; 2018 Jan; 8(1):1319. PubMed ID: 29358722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.
    Abdullaha M; Nuthakki VK; Bharate SB
    Eur J Med Chem; 2020 Dec; 207():112761. PubMed ID: 32942070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
    Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
    Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone status of adult female butyrylcholinesterase gene-deficient mice.
    Haupt M; Kauschke V; Sender J; Kampschulte M; Kovtun A; Dürselen L; Heiss C; Lips KS
    Int Immunopharmacol; 2015 Nov; 29(1):208-14. PubMed ID: 26138460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
    Lane RM; Potkin SG; Enz A
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of cholinesterases in chagas disease.
    Seabra HF; Campello AC; Chagas EFG; Martins LPA; Suzuki RB; Ruiz MO; Donadi EA; Baleotti W
    Parasitol Int; 2023 Feb; 92():102659. PubMed ID: 36029960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research.
    Kopańska M; Batoryna M; Bartman P; Szczygielski J; Banaś-Ząbczyk A
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.